Manejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casos

Vista sencilla de ítem
dc.contributor.advisorAmaris Peña, Oscarspa
dc.contributor.advisorPinilla Bonilla, Laura Bibianaspa
dc.contributor.authorPatiño Soler, Mauriciospa
dc.date.accessioned2024-02-26T19:37:52Z
dc.date.available2024-02-26T19:37:52Z
dc.date.issued2024
dc.descriptionilustraciones, diagramasspa
dc.description.abstractLa vacunación contra SARS-Cov-2 ha disminuido la tasa de infección, severidad y mortalidad por COVID-19. Estudios sobre la respuesta inmune a las vacunas muestran un aumento en marcadores inflamatorios, algunos similares a COVID-19 severa. Algunos pacientes generan el síndrome post-vacuna de COVID-19, se ha propuesto que una respuesta inflamatoria persistente y la disfunción del nervio vago como explicación. La medicina neuralterapéutica puede ser usada para la regulación del sistema nervioso. Presentación de casos. Caso 1: Paciente femenina de 52 años con dolor crónico con aumento del dolor musculoesquelético posterior a la segunda dosis contra COVID-19. Caso 2: Paciente femenina de 73 años con dolor crónico en miembros superiores posterior a recibir vacunación contra COVID-19. Caso 3: Paciente femenina de 75 años con aparición de dolor en miembro superior derecho, rodillas y zona lumbar posterior a la vacunación contra COVID-19. Después del tratamiento con medicina neuralterapéutica hubo disminución del dolor en los tres casos. Conclusión. El dolor musculoesquelético posterior a vacunación contra COVID-19 es un efecto adverso que puede aparecer en partes distantes al sitio de vacunación. Los reportes de caso presentados describen la utilización de la medicina neuralterapéutica como una herramienta para el tratamiento de los síntomas post-vacunación. (Texto tomado de la fuente).spa
dc.description.abstractVaccination against SARS-Cov-2 has decreased the rate of infection, severity, and mortality rate from COVID-19. Studies on the immune response to vaccines show increased inflammatory markers, some similar to severe COVID-19. Some patients develop post-COVID-19 vaccine syndrome, a persistent inflammatory response, and vagus nerve dysfunction have been proposed as an explanation. Neuraltherapeutic medicine can be used for the regulation of the nervous system. Presentation of cases. Case 1: 52-year-old female patient with chronic pain with increased musculoskeletal pain after the second dose against COVID-19. Case 2: 73-year-old female patient with chronic pain in the upper limbs after receiving vaccination against COVID-19. Case 3: 75-year-old female patient with pain in the right upper limb, knees, and lower back after vaccination against COVID-19. After treatment with neuraltherapeutic medicine, there was a decrease in pain in all three cases. Conclusion. Musculoskeletal pain after vaccination against COVID-19 is an adverse effect that can appear in parts distant from the vaccination site. The case reports presented describe the use of neural therapeutic medicine as a tool for the treatment of postvaccination symptoms.eng
dc.description.degreelevelMaestríaspa
dc.description.degreenameMagíster en Medicina Alternativaspa
dc.description.methodsEstudio no experimental, descriptivo retrospectivo longitudinalspa
dc.format.extentxii, 21 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/85722
dc.language.isospaspa
dc.publisherUniversidad Nacional de Colombiaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.placeBogotá, Colombiaspa
dc.publisher.programBogotá - Medicina - Maestría en Medicina Alternativaspa
dc.relation.indexedBiremespa
dc.relation.referencesCucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed [Internet]. 2020 [cited 2022 Jun 8];91(1):157–60. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569573/spa
dc.relation.referencesMiller E. Rapid evaluation of the safety of COVID-19 vaccines: how well have we done? Commentary on “Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study.” Clinical Microbiology and Infection [Internet]. 2022 Jan 5 [cited 2022 Jan 26];0(0). Available from: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00726-6/fulltext#secsectitle0015spa
dc.relation.referencesKannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies. Journal of Autoimmunity [Internet]. 2022 Jan 1 [cited 2022 Jan 20];126:102779. Available from: https://www.sciencedirect.com/science/article/pii/S0896841121001876spa
dc.relation.referencesStanghellini MTL, Cosimo SD, Costantini M, Monti S, Mantegazza R, Mantovani A, et al. mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients [Internet]. Oncology; 2022 Jan [cited 2022 Jan 26]. Available from: http://medrxiv.org/lookup/doi/10.1101/2022.01.18.22269351spa
dc.relation.referencesRenoud L, Khouri C, Revol B, Lepelley M, Perez J, Roustit M, et al. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database. JAMA Internal Medicine [Internet]. 2021 Sep 1 [cited 2022 Jan 26];181(9):1243–5. Available from: https://doi.org/10.1001/jamainternmed.2021.2219spa
dc.relation.referencesPatone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med [Internet]. 2021 Dec [cited 2022 Jan 26];27(12):2144–53. Available from: https://www.nature.com/articles/s41591-021-01556-7spa
dc.relation.referencesSodhi M, Samii A, Etminan M. A comparative safety study of reported neurological adverse events with three COVID-19 vaccines. J Neurol [Internet]. 2022 Jan 9 [cited 2022 Jan 26]; Available from: https://doi.org/10.1007/s00415-021-10919-6spa
dc.relation.referencesPottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ [Internet]. 2021 May 5 [cited 2022 Jan 26];373:n1114. Available from: https://www.bmj.com/content/373/bmj.n1114spa
dc.relation.referencesNdeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igyártó BZ. The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience [Internet]. 2021 Dec 17 [cited 2022 Jan 27];24(12):103479. Available from: https://www.sciencedirect.com/science/article/pii/S2589004221014504spa
dc.relation.referencesGundry SR. Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation [Internet]. 2021 Nov 16 [cited 2022 Jan 27];144(Suppl_1):A10712–A10712. Available from: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712spa
dc.relation.referencesLiu J, Wang J, Xu J, Xia H, Wang Y, Zhang C, et al. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines | Cell Discovery. Cell Discov [Internet]. 2021 Oct 26 [cited 2022 Feb 8];(99). Available from: https://www.nature.com/articles/s41421-021-00329-3spa
dc.relation.referencesAlsaiari AA, Allahyani M, Aljuaid A, Shafie A, Al-hazmi A, Dahlawi HA, et al. Assessing the adverse effects of COVID-19 vaccine in different scenarios in Saudi Arabia. Saudi Med J [Internet]. 2023 Feb [cited 2023 Mar 28];44(2):194–201. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987704/spa
dc.relation.referencesSpinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, et al. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Research & Therapy [Internet]. 2022 Jan 11 [cited 2023 Mar 28];24(1):21. Available from: https://doi.org/10.1186/s13075-021-02674-wspa
dc.relation.referencesAcanfora D, Nolano M, Acanfora C, Colella C, Provitera V, Caporaso G, et al. Impaired Vagal Activity in Long-COVID-19 Patients. Viruses [Internet]. 2022 May [cited 2023 May 26];14(5):1035. Available from: https://www.mdpi.com/1999-4915/14/5/1035spa
dc.relation.referencesJara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol [Internet]. 2022 [cited 2023 May 26];41(5):1603–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979721/spa
dc.relation.referencesFinsterer J. Neurological side effects of SARS‐CoV‐2 vaccinations. Acta Neurol Scand [Internet]. 2022 Jan [cited 2023 May 26];145(1):5–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653194/spa
dc.relation.referencesOonk NGM, Ettema AR, van Berghem H, de Klerk JJ, van der Vegt JPM, van der Meulen M. SARS-CoV-2 vaccine-related neurological complications. Neurol Sci [Internet]. 2022 Jan 20 [cited 2022 Jan 26]; Available from: https://doi.org/10.1007/s10072-022-05898-zspa
dc.relation.referencesPavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci [Internet]. 2017 Feb [cited 2023 May 26];20(2):156–66. Available from: https://www.nature.com/articles/nn.4477spa
dc.relation.referencesJohnson RL, Wilson CG. A review of vagus nerve stimulation as a therapeutic intervention. J Inflamm Res [Internet]. 2018 May 16 [cited 2023 May 26];11:203–13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961632/spa
dc.relation.referencesVischnevsky AV, Vischnevsky AA. El bloqueo novocainico y los antisépticos oleobalsámicos como forma de terapéutica patogénica. Argentina: Editorial Cartago; 1958. 200 p.spa
dc.relation.referencesBustamante C, Pinilla L, Amaris O. An Approach to Acute SARS-CoV-2 Management with Complementary Neuraltherapeutic Medicine: A Case Report. Clin Med Insights Case Rep [Internet]. 2023 Apr 5 [cited 2023 May 26];16:11795476231159584. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076607/spa
dc.relation.referencesKawano-Hokama M, Shiratori-Tusita L, Pinilla-Bonilla L, Cruz-Rodríguez Y. The potential role of trigeminal nerve irritation in the pathophysiology of Bell’s palsy. A case report from a Neural Therapy perspective. Case reports [Internet]. 2022;8(2). Available from: https://revistas.unal.edu.co/index.php/care/article/view/93840spa
dc.relation.referencesAsociación Colombiana de Terapia Neural / Medicina Neuralterapéutica (ACOLTEN/MNT), Asociación Colombiana de Terapia Neural Julio César Payán de la Roche. Asociación Colombiana de Terapia Neural (ACOLTEN MNT) en contexto de pandemia. Colombia; 2020 Jun p. 83.spa
dc.relation.referencesEngel R, Barop H, Giebel J, Ludin SM, Fischer L. The Influence of Modern Neurophysiology on the Previous Definitions of “Segment” and “Interference Field” in Neural Therapy. Complement Med Res [Internet]. 2022 [cited 2022 Jun 27];29(3):257–67. Available from: https://www.karger.com/Article/FullText/522391spa
dc.relation.referencesPolymyalgia Rheumatica After ChAdOx1 nCov-19 Vaccine: A Case Report - PMC [Internet]. [cited 2023 Sep 23]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236670/spa
dc.relation.referencesPinilla L. Validez y fuerza científica de los fundamentos de la Terapia Neural: un estudio de la obra de Speransky. In: Medicina neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá: Universidad Nacional de Colombia; 2013.spa
dc.relation.referencesToscano de la Torre F, Pinilla Bonilla LB. Los principios de la terapia neural desde los fundamentos del nervismo hasta la neurociencia actual. Rev Univ Ind Santander Salud [Internet]. 2012 [cited 2022 Jan 27];44(2):57–65. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072012000200008spa
dc.relation.referencesSalazar J. La terapia neural: de terapia {ortodoxa" a Medicina Neuralterapéutica. In: Medicina Neuralterapéutica: un abordaje desde los sistemas médicos complejos. Bogotá: Universidad Nacional de Colombia; 2013. p. 51–72.spa
dc.relation.referencesVinyes D, Muñoz-Sellart M, Caballero TG. Local anesthetics as a therapeutic tool for post COVID-19 patients: A case report. Medicine [Internet]. 2022 Jul 15 [cited 2023 May 26];101(28):e29358. Available from: https://journals.lww.com/md-journal/Fulltext/2022/07150/Local_anesthetics_as_a_therapeutic_tool_for_post.33.aspxspa
dc.relation.referencesAltinbilek T, Terzi R, Kaya E, Murat S. Effects of Local Anesthetics on Viruses from a Neural Therapy Perspective. J Tradit Complem Med. 2021;4(3):394–9.spa
dc.relation.referencesFu Q, Xie H, Zhou L, Li X, Liu Y, Liu M, et al. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial. Trials [Internet]. 2021 Feb 25 [cited 2023 Sep 27];22:162. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905419/spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.ddc610 - Medicina y salud::615 - Farmacología y terapéuticaspa
dc.subject.ddc610 - Medicina y salud::616 - Enfermedadesspa
dc.subject.decsSíndrome Post Agudo de COVID-19spa
dc.subject.decsPain Management/methodseng
dc.subject.decsPost-Acute COVID-19 Syndromeeng
dc.subject.decsTerapias Complementariasspa
dc.subject.decsComplementary Therapieseng
dc.subject.decsManejo del Dolor/métodosspa
dc.subject.proposalPost-vacuna COVID-19spa
dc.subject.proposalMedicina neuralterapéuticaspa
dc.subject.proposalDolor musculoesqueléticospa
dc.subject.proposalMedicina alternativaspa
dc.subject.proposalPost-COVID-19 vaccineeng
dc.subject.proposalNeural therapeutic medicineeng
dc.subject.proposalMusculoskeletal paineng
dc.subject.proposalAlternative medicineeng
dc.titleManejo de dolor musculoesquelético post-vacuna contra COVID-19 con medicina neuralterapéutica: serie de casosspa
dc.title.translatedThe onset of musculeskeletal pain managment after the COVID-19 vaccine with neuraltherapeutic medicine treatment: Serieseng
dc.typeTrabajo de grado - Maestríaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentEstudiantesspa
dcterms.audience.professionaldevelopmentPúblico generalspa
dcterms.audience.professionaldevelopmentReceptores de fondos federales y solicitantesspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
1125785403.2024.pdf
Tamaño:
234.72 KB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de Maestría en Medicina Alternativa
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
5.74 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Maestría en Medicina Alternativa